Stocks and Investing
Stocks and Investing
Tue, September 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $381 on, Sep 5th, 2023
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $363 to $381 on, Sep 5th, 2023.
Matthew has made no other calls on BIIB in the last 4 months.
There are 17 other peers that have a rating on BIIB. Out of the 17 peers that are also analyzing BIIB, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $275 on, Tuesday, August 8th, 2023
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $294 on, Tuesday, August 8th, 2023
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $268 on, Wednesday, July 26th, 2023
These are the ratings of the 14 analyists that currently disagree with Matthew
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $357 on, Tuesday, August 29th, 2023
- Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $335 on, Monday, August 14th, 2023
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $340 on, Tuesday, August 8th, 2023
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $305 on, Tuesday, August 8th, 2023
- Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $336 on, Tuesday, August 8th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Monday, August 7th, 2023
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $343 on, Monday, August 7th, 2023
- George Farmer of "Scotiabank" Initiated at Buy and Held Target at $327 on, Thursday, July 27th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, July 26th, 2023
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $320 on, Tuesday, July 25th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $350 on, Monday, June 12th, 2023
- Brian Skorney of "Baird" Reiterated at Buy and Held Target at $340 on, Wednesday, June 7th, 2023
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $360 on, Thursday, June 1st, 2023
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Thursday, May 11th, 2023
Contributing Sources